Krobert Kurt A, Andressen Kjetil Wessel, Levy Finn Olav
Department of Pharmacology and Center for Heart Failure Research, University of Oslo, Blindern, N-0316 Oslo, Norway.
Eur J Pharmacol. 2006 Feb 17;532(1-2):1-10. doi: 10.1016/j.ejphar.2005.11.039.
Previously, we demonstrated that human serotonin (5-HT) 5-HT(7) receptors display marked constitutive activity. Here, we tested if the constitutive activation of adenylyl cyclase by 5-HT(7) receptors influenced both the desensitization properties of transfected 5-HT(7) receptors and the ability of endogenous G(s)-coupled receptors to activate adenylyl cyclase. Using membranes from stably transfected HEK293 cells expressing the recombinant human 5-HT(7) receptor splice variants (5-HT(7(a)), 5-HT(7(b)) and 5-HT(7(d))), we compared the effects of 1-h or 24-h preincubation of the agonist 5-HT, partial inverse agonists mesulergine and SB269970, and full inverse agonists clozapine and methiothepin on subsequent activation of adenylyl cyclase by both 5-HT through transfected 5-HT(7) receptors and the endogenous G(s)-coupled beta-adrenoceptors and prostaglandin receptors of HEK293 cells. The data show that stable expression of 5-HT(7) receptors is sufficient to attenuate adenylyl cyclase activation by endogenous G(s)-coupled receptors. Interestingly, preincubation with inverse agonists not only failed to result in the predicted resensitization of all receptor mediated adenylyl cyclase activation, but some inverse agonists further attenuated (desensitized) beta-adrenoceptor and prostaglandin-stimulated adenylyl cyclase activation similar to long-term agonist exposure by 5-HT. These effects were not correlated with inverse agonist efficacy, were not accompanied by receptor down-regulation and appear to be mediated by a protein kinase A (PKA) independent mechanism. It is concluded that the human 5-HT(7) receptor mediates heterologous desensitization of endogenous G(s)-coupled receptors through an unknown and potentially novel mechanism.
此前,我们证明了人类5-羟色胺(5-HT)5-HT(7)受体具有显著的组成性活性。在此,我们测试了5-HT(7)受体对腺苷酸环化酶的组成性激活是否会影响转染的5-HT(7)受体的脱敏特性以及内源性G(s)偶联受体激活腺苷酸环化酶的能力。我们使用稳定转染表达重组人类5-HT(7)受体剪接变体(5-HT(7(a))、5-HT(7(b))和5-HT(7(d)))的HEK293细胞的膜,比较了激动剂5-HT、部分反向激动剂美舒麦角和SB269970以及完全反向激动剂氯氮平和甲硫噻平1小时或24小时预孵育对随后通过转染的5-HT(7)受体的5-HT以及HEK293细胞的内源性G(s)偶联β-肾上腺素能受体和前列腺素受体激活腺苷酸环化酶的影响。数据表明,5-HT(7)受体的稳定表达足以减弱内源性G(s)偶联受体对腺苷酸环化酶的激活。有趣的是,用反向激动剂预孵育不仅未能导致所有受体介导的腺苷酸环化酶激活的预期再敏化,而且一些反向激动剂进一步减弱(脱敏)了β-肾上腺素能受体和前列腺素刺激的腺苷酸环化酶激活,类似于5-HT长期激动剂暴露的情况。这些效应与反向激动剂的效力无关,不伴有受体下调,并且似乎由一种不依赖蛋白激酶A(PKA)的机制介导。结论是,人类5-HT(7)受体通过一种未知且可能新颖的机制介导内源性G(s)偶联受体的异源脱敏。